PPIDT00147
Drug Information
| Name | Ecallantide |
|---|---|
| Sequence | EAMHSFCAFKADDGPCRAAHPRWFFNIFTRQCEEFIYGGCEGNQNRFESLEECKKMCTRD |
| DrugBank_ID | DB05311 |
| Type | biotech |
| Indication | Indicated for the symptomatic treatment of acute attacks of hereditary angioedema (HAE) in patients 12 years of age and older [FDA Label]. |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Injection, solution | Subcutaneous |
10 mg/1mL
|
| Solution | Subcutaneous |
1000000 mg
|